Package 68788-8677-9

{"route": ["ORAL"], "spl_id": "edc17f66-29a3-4a9a-8d2c-35823c94c269", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993557"], "spl_set_id": ["b6ff6229-4dfa-4f23-b5f4-5edbf93b879d"], "manufacturer_name": ["Preferred Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8677-1)", "package_ndc": "68788-8677-1", "marketing_start_date": "20240523"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8677-3)", "package_ndc": "68788-8677-3", "marketing_start_date": "20240523"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8677-6)", "package_ndc": "68788-8677-6", "marketing_start_date": "20240523"}, {"sample": false, "description": "120 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8677-8)", "package_ndc": "68788-8677-8", "marketing_start_date": "20240523"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8677-9)", "package_ndc": "68788-8677-9", "marketing_start_date": "20240523"}], "brand_name": "Bupropion Hydrochloride", "product_id": "68788-8677_edc17f66-29a3-4a9a-8d2c-35823c94c269", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "68788-8677", "generic_name": "Bupropion Hydrochloride", "labeler_name": "Preferred Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA090693", "marketing_category": "ANDA", "marketing_start_date": "20240523", "listing_expiration_date": "20261231"}